World's Best Scientists 2026 revealed!
Qiang Pan-Hammarström

Qiang Pan-Hammarström

D-Index & Metrics

Immunology

D-Index
72
Citations
19831
World Ranking
2207
National Ranking
41

Overview

Qiang Pan-Hammarström is affiliated with the Karolinska Institute in Sweden and has an extensive research output primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work encompasses a range of subfields including Infectious Diseases, Immunology, Molecular Biology, Genetics, and Epidemiology.

The main topics that define their research contributions are as follows:

  • SARS-CoV-2 and COVID-19 Research
  • Immunodeficiency and Autoimmune Disorders
  • COVID-19 Clinical Research Studies
  • Lymphoma Diagnosis and Treatment
  • Immune Cell Function and Interaction
  • Monoclonal and Polyclonal Antibodies Research
  • Chronic Lymphocytic Leukemia Research

The scientist has published multiple papers in notable venues, with frequent appearances in bioRxiv (Cold Spring Harbor Laboratory), Nature Communications, The Journal of Experimental Medicine, Science Immunology, and the Journal of Allergy and Clinical Immunology.

Some recent papers include:

  • "Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths" (2021, Science Immunology)
  • "X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19" (2021, Science Immunology)
  • "Genomic basis for RNA alterations in cancer" (2020, Nature)
  • "Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection" (2021, Med)
  • "SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways" (2020, Cancer Cell)

Their frequent co-authors reflect collaboration with other researchers, including Lennart Hammarström, Likun Du, Hassan Abolhassani, Harold Marcotte, and Jean-Laurent Casanova.

Best Publications

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans

    U Salzer;H M Chapel;A D B Webster;Q Pan-Hammarström

  • Deleterious Mutations in LRBA Are Associated with a Syndrome of Immune Deficiency and Autoimmunity

    Gabriela Lopez-Herrera;Giacomo Tampella;Qiang Pan-Hammarström;Peer Herholz

  • Human genetic and immunological determinants of critical COVID-19 pneumonia

    Unknown

  • B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans

    Klaus Warnatz;Ulrich Salzer;Marta Rizzi;Beate Fischer

  • X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.

    Takaki Asano;Bertrand Boisson;Bertrand Boisson;Bertrand Boisson;Fanny Onodi;Daniela Matuozzo;Daniela Matuozzo

  • Genomic basis for RNA alterations in cancer

    Claudia Calabrese;Natalie R. Davidson;Deniz Demircioğlu;Deniz Demircioğlu;Nuno A. Fonseca

  • Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency.

    Qiang Pan-Hammarström;Ulrich Salzer;Likun Du;Jan Fredrik Björkander

  • B Cell Super-Enhancers and Regulatory Clusters Recruit AID Tumorigenic Activity.

    Jason Qian;Qiao Wang;Marei Dose;Nathanael Pruett

  • Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes.

    Ulrich Salzer;Chiara Bacchelli;Sylvie Buckridge;Qiang Pan-Hammarström

  • Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR

    Stephan Borte;Ulrika von Döbeln;Anders Fasth;Ning Wang

  • Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases

    John D. Rioux;John D. Rioux;Philippe Goyette;Philippe Goyette

  • The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

    Unknown

  • Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant

    Unknown

  • Genetic landscapes of relapsed and refractory diffuse large B cell lymphomas

    Ryan D. Morin;Sarit Assouline;Miguel Alcaide;Arezoo Mohajeri

  • Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas

    Konstantinos Georgiou;Longyun Chen;Mattias Berglund;Weicheng Ren

  • Selective IgA deficiency in early life: association to infections and allergic diseases during childhood.

    Magdalena Janzi;Inger Kull;Ronald Sjöberg;Jinghong Wan

  • Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children

    Unknown

  • Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency

    Ricardo C Ferreira;Qiang Pan-Hammarström;Robert R Graham;Vesela Gateva

  • Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.

    Peter K. Gregersen;Roman Kosoy;Annette T. Lee;Janine Lamb

  • Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea

    Neha Pant;Anna Hultberg;Yaofeng Zhao;Lennart Svensson

  • Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection.

    Natalia Sherina;Antonio Piralla;Likun Du;Hui Wan

  • Role for Msh5 in the regulation of Ig class switch recombination.

    Hideharu Sekine;Ricardo C. Ferreira;Qiang Pan-Hammarström;Robert R. Graham

  • Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection

    Natalia Sherina;Antonio Piralla;Likun Du;Hui Wan

  • Relevance of biallelic vs monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes

    U S Salzer;C Bacchelli;S Buckridge;Q Pan-Hammar-Strom

Frequent Co-Authors

Lennart Hammarström
Lennart Hammarström Karolinska Institute
Asghar Aghamohammadi
Asghar Aghamohammadi Tehran University of Medical Sciences
Nima Rezaei
Nima Rezaei Tehran University of Medical Sciences
Ulrich Salzer
Ulrich Salzer University of Freiburg
Andrew R. Gennery
Andrew R. Gennery Newcastle University
Bodo Grimbacher
Bodo Grimbacher University of Freiburg
Timothy W. Behrens
Timothy W. Behrens Xaira Therapeutics
Stuart G. Tangye
Stuart G. Tangye Garvan Institute of Medical Research
Richard Rosenquist
Richard Rosenquist Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse healthcare careers, many of which benefit from specialized nursing education. For nurses aiming to advance their career, the transition from a Family Nurse Practitioner to a more specialized role is common. Programs focused on fnp to acute care np provide the necessary skills for acute patient management, complementing immunology expertise.

For those looking to accelerate their nurse practitioner education, pursuing an accelerated fnp program online can be a time-efficient path. These programs combine rigorous coursework with clinical experience, preparing graduates to handle complex immunological conditions in clinical settings.

Non-nurses interested in healthcare and immunology can start with online nursing programs designed for beginners. High-quality online absn programs for non nurses make it possible to enter nursing with a focus on immunology topics, broadening career opportunities.

Choosing the right accelerated Bachelor of Science in Nursing program is critical. Programs with low barriers to entry are ideal for many students and can be found by exploring absn programs with high acceptance rates. This flexibility helps prospective immunology students transition smoothly into nursing careers that support their interests.

Best Scientists Citing Qiang Pan-Hammarström

Trending Scientists

Recently Published Articles